Alkaloids and saponins as cytochrome P450 inhibitors from blue cohosh (Caulophyllum thalictroides) in an in vitro assay

Planta Medica

Volumn 75, Issue 4, 2009, Pages 329-332

  Madgula, Vamsi L M ^a   Ali, Zulfiqar ^a   Smillie, Troy ^a   Khan, Ikhlas A ^a,b   Walker, Larry A ^a,b   Khan, Shabana I ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID DERIVATIVE; ANAGYRINE; CAULOPHYLLINE; CAULOPHYLLUM THALICTROIDES EXTRACT; CAULOPHYLLUMINE B; CAULOSIDE C; CAULOSIDE D; CAULOSIDE G; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; CYTOCHROME P450 INHIBITOR; DRUG METABOLIZING ENZYME; FURAFYLLINE; KETOCONAZOLE; LUPANINE; O ACETLYBAPTIFOLIN; PIPERIDINE DERIVATIVE; PLANT EXTRACT; QUINIDINE; SAPONIN DERIVATIVE; TRANYLCYPROMINE; UNCLASSIFIED DRUG; ALKALOID; CYTOCHROME P450; SAPONIN;

ARTICLE; CATALYSIS; CAULOPHYLLUM; CAULOPHYLLUM THALICTROIDES; DIET SUPPLEMENTATION; DRUG ACTIVITY; DRUG EFFECT; DRUG ISOLATION; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; FOOD DRUG INTERACTION; IN VITRO STUDY; PLANT ROOT; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM;

CAULOPHYLLUM; CAULOPHYLLUM THALICTROIDES;

ALKALOIDS; CAULOPHYLLUM; CYTOCHROME P-450 ENZYME SYSTEM; MOLECULAR STRUCTURE; SAPONINS;

EID: 65649087056     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0028-1112207     Document Type: Article

References (13)

1. Dugoua JJ, Perri D, Seely D, Mills E, Koren G. Safety and efficacy of blue cohosh (Caulophyllum thalictroides) during pregnancy and lactation. Can J Clin Pharmacol 2008; 15: 66-73 (Pubitemid 351162490)
2. Kennelly EJ, Flynn TJ, Mazzola EP, Roach JA, McCloud TG, Danford DE. Detecting potential teratogenic alkaloids from blue cohosh rhizomes using an in vitro rat embryo culture. J Nat Prod 1999; 62: 1385-1389
3. Schmeller S, Sauerwein M, Sporer F, Wink M, Muller WE. Binding of quinolizidine alkaloids to nicotinic and muscarinic acetylcholine receptors. J Nat Prod 1994; 57: 1316-1319 (Pubitemid 24333052)
4. Tyler VE. Blue cohosh. Binghamton: The Haworth Herbal Press; 1999: 55-56
5. Coon N. Familiar medicinal plants. Emmaus: Rodale Press; 1979: 81
6. Butterweck V, Derendorf H, Gaus W, Nahrstedt A, Schulz V, Unger M. Pharmacokinetic herb-drug interactions: Are preventive screenings necessary and appropriate? Planta Med 2004; 70: 784-791
7. Food and Drug Administration. Drug interaction studies: study design data analysis, and implications for dosing and labelling. CDER, U.S Department of Health and Human Services, CBER, FDA; 2004
8. Liu Y, Yang L. Earlymetabolism evaluation making Traditional Chinese Medicine effective and safe therapeutics. J Zhejiang Univ Sci B 2006; 7: 99-106
9. Barone GW, Gurley BJ, Ketel BL, Lightfoot ML, Abul-Ezz SR. Drug interactions between St. John's wort and cyclosporine. Ann Pharmacother 2000; 34: 239-255
10. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. New Engl J Med 1997; 336: 1108
11. Usia T, Iwata H, Hiratsuka A, Watabe T, Kadota S, Tezuka Y. CYP3A4 and CYP2D6 inhibitory activities of Indonesian medicinal plants. 2006; 3: 67-73.
12. Ali Z, Khan IA. Alkaloids and saponins from blue cohosh. Phytochemistry 2008; 69: 1037-1042
13. Crespi CL, Miller VP, Penman BW. Microtiter plate assays for inhibition of human drug-metabolizing cytochromes P450. Anal Biochem 1997; 248: 188-90